|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash flows from operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation expense | |||||
| Change in fair value of warrant liability | |||||
| Loss on disposal of intangible asset | |||||
| Financing expense | |||||
| Net realized and unrealized gains on marketable securities | |||||
| Amortization of operating lease right-of-use asset | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other current assets | |||||
| Other assets and liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operations | |||||
| Investing activities: | |||||
| Addition of intangible asset | |||||
| Proceeds from sales of marketable securities | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Issuance of Common Stock and warrants from offering, net | |||||
| Proceeds from exercise of Series J Convertible Preferred Warrants | |||||
| Proceeds from exercise of April 2024 Warrants, net | |||||
| Issuance of July and August 2024 Common Stock and Warrants, net | |||||
| Proceeds from warrant inducement in November 2024, net | |||||
| Proceeds from the exercise of warrants, net | |||||
| Payments on finance lease liability | |||||
| Issuance of Common Stock from ATM, net | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash—beginning of year | |||||
| Cash, cash equivalents and restricted cash—end of year | |||||
| Supplemental schedule of non-cash activities | |||||
| Inventory transferred to property, plant and equipment | |||||
| Issuance of Common Stock for exercise of Series I Warrants | |||||
| Issuance of Series J Preferred Stock for exercise of Warrants | |||||
| Reclassification of April 2024 warrants to equity | |||||
| Series A warrants conversion to equity | |||||
| Series B warrant exercises | |||||
| Issuance of Common Stock for conversion | |||||
| Series F-1 Convertible Preferred Stock | |||||
| Series J Convertible Preferred Stock | |||||
| Total issuance of Common Stock for conversion | |||||
| Series J Preferred Stock issued for payment in kind dividend | |||||
| Deemed dividend on Series J Preferred Stock | |||||
| Supplemental cash flow information | |||||
| Cash paid for income taxes | |||||
Loading...